Literature DB >> 9732255

Endoscopic third ventriculostomy: an outcome analysis.

D Brockmeyer1, K Abtin, L Carey, M L Walker.   

Abstract

Endoscopic third ventriculostomy (ETV) has gained widespread acceptance as an effective way to manage hydrocephalus in selected patients. To determine which patient groups have the highest chance of successful ETV, a retrospective case review was performed. From June 1992 to December 1996, 97 patients underwent a total of 98 ETVs at our institution. There were 59 males and 38 females with a mean age of 8.1 years (range 1 day to 29.5 years). Twenty-six of 98 procedures (26%) were abandoned due to either unfavorable anatomy, inability to perform a cisternostomy, or hemorrhage. Follow-up data was available in 92 patients for a mean of 24.2 months. The rate of successful ETV in 71 patients, with either complete shunt avoidance or removal, varied widely by diagnosis and patient age. The highest success rates were achieved in patients with aqueductal stenosis, tectal plate tumor, myelomeningocele and posterior fossa tumor. Complications included one transient herniation syndrome, one basilar artery perforation, 2 cases of ventriculitis, one transient decrease in level of consciousness, and one transient hemiparesis. We feel these results support the continued use of ETV in only carefully selected patients with hydrocephalus.

Entities:  

Mesh:

Year:  1998        PMID: 9732255     DOI: 10.1159/000028657

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  48 in total

1.  Hydrocephalus--what's new?

Authors:  P Chumas; A Tyagi; J Livingston
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-11       Impact factor: 5.747

Review 2.  Long-term complications and definition of failure of neuroendoscopic procedures.

Authors:  Tjemme Beems; J Andre Grotenhuis
Journal:  Childs Nerv Syst       Date:  2004-06-10       Impact factor: 1.475

Review 3.  Use of endoscopic third ventriculostomy in hydrocephalus of tubercular origin.

Authors:  Sanat Bhagwati; Nirav Mehta; Suneel Shah
Journal:  Childs Nerv Syst       Date:  2010-05-28       Impact factor: 1.475

Review 4.  Success and failure of endoscopic third ventriculostomy in young infants: are there different age distributions?

Authors:  Dorothee Koch-Wiewrodt; Wolfgang Wagner
Journal:  Childs Nerv Syst       Date:  2006-08-30       Impact factor: 1.475

Review 5.  The role of different imaging modalities: is MRI a conditio sine qua non for ETV?

Authors:  Erik J van Lindert; Tjemme Beems; J André Grotenhuis
Journal:  Childs Nerv Syst       Date:  2006-08-30       Impact factor: 1.475

6.  Third ventriculostomy vs ventriculoperitoneal shunt in pediatric obstructive hydrocephalus: results from a Swiss series and literature review.

Authors:  Sandrine de Ribaupierre; B Rilliet; O Vernet; L Regli; J-G Villemure
Journal:  Childs Nerv Syst       Date:  2007-01-17       Impact factor: 1.475

Review 7.  Development and content validation of performance assessments for endoscopic third ventriculostomy.

Authors:  Gerben E Breimer; Faizal A Haji; Eelco W Hoving; James M Drake
Journal:  Childs Nerv Syst       Date:  2015-05-01       Impact factor: 1.475

Review 8.  Endoscopic third ventriculostomy for obstructive hydrocephalus.

Authors:  Dieter Hellwig; Joachim Andreas Grotenhuis; Wuttipong Tirakotai; Thomas Riegel; Dirk Michael Schulte; Bernhard Ludwig Bauer; Helmut Bertalanffy
Journal:  Neurosurg Rev       Date:  2004-11-27       Impact factor: 3.042

9.  The role of the Liliequist membrane in the third ventriculostomy.

Authors:  José Aloysio da Costa Val Filho; Sebastião Nataniel da Silva Gusmão; Leopoldo Mandic Ferreira Furtado; Guaracy de Macedo Machado Filho; Fernando Levi Alencar Maciel
Journal:  Neurosurg Rev       Date:  2021-02-23       Impact factor: 3.042

10.  Effect of endoscopic third ventriculostomy on neuropsychological outcome in late onset idiopathic aqueduct stenosis: a prospective study.

Authors:  J Burtscher; L Bartha; K Twerdy; W Eisner; T Benke
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.